Company HBM Healthcare Investments AG
Equities
HBMN
CH0012627250
Investment Management & Fund Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
186.8 CHF | +0.21% | +0.21% | +2.30% |
Business Summary
Number of employees: 700
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100.0
%
| -74 | 100.0 % | -117 | 100.0 % | +57.95% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| -74 | 100.0 % | -117 | 100.0 % | +57.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andreas Wicki
CEO | Chief Executive Officer | 64 | 01-06-30 |
Erwin Troxler
DFI | Director of Finance/CFO | 54 | 11-10-31 |
Benedikt Suter
SEC | Corporate Secretary | 60 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 09-05-31 | |
Elaine Jones
BRD | Director/Board Member | 69 | 21-06-17 |
Mario Giuliani
BRD | Director/Board Member | 52 | 11-12-31 |
Rudolf Lanz
BRD | Director/Board Member | 73 | 02-12-31 |
Benedikt Suter
SEC | Corporate Secretary | 60 | - |
Stella Xu
BRD | Director/Board Member | 53 | 20-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,960,000 | 5,714,984 ( 82.11 %) | 48,620 ( 0.6986 %) | 82.11 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BENITEC BIOPHARMA INC. 32.46% | 841,395 | 32.46% | 4,417,324 $ |
2,910 | 0.04% | 625,487 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
HBM Healthcare Investments (Cayman) Ltd.
HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The private company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. |
Hospital/Nursing Management
|
HBM Private Equity India
HBM Private Equity India Financial ConglomeratesFinance Part of HBM Partners AG, HBM Private Equity India is an Indian company that provides investment services. |
Financial Conglomerates
|
Swixx Biopharma SA
Swixx Biopharma SA Miscellaneous Commercial ServicesCommercial Services Swixx Biopharma SA provides marketing and sales, regulatory, medical affairs, cold chain, logistic services to pharmaceutical companies. Its services also include receivables, collection, FX coverage, risk management, compliance, and reimbursement and market access. The company was founded by Petr Nemec and Robert Stuart Swanson in 2013 and is headquartered in Baar, Switzerland. |
Miscellaneous Commercial Services
|
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.30% | 1.4B | |
+31.41% | 12.02B | |
+15.54% | 3.09B | |
+2.49% | 663M | |
+38.32% | 616M | |
+1.15% | 613M | |
-4.17% | 493M | |
+30.43% | 473M | |
+3.90% | 305M | |
+21.52% | 295M |
- Stock Market
- Equities
- HBMN Stock
- Company HBM Healthcare Investments AG